These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 436934)

  • 21. Hyperglycaemic effect of glucagon administered intracerebroventricularly in the rat.
    Marubashi S; Tominaga M; Katagiri T; Yamatani K; Yawata Y; Hara M; Sasaki H
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):6-10. PubMed ID: 2857512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenergic blockade prevents endotoxin-induced increases in glucose metabolism.
    Hargrove DM; Bagby GJ; Lang CH; Spitzer JJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):E629-35. PubMed ID: 2903674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose, glucagon, and insulin during adrenergic blockade in exercising sheep.
    Brockman RP; Halvorson R
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Feb; 52(2):315-9. PubMed ID: 7037712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice.
    Ahrén B; Lindskog S; Tatemoto K; Efendić S
    Diabetes; 1988 Mar; 37(3):281-5. PubMed ID: 3286328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of phentolamine on the insulin, glucagon, and glucose responses to exercise in adrenal-denervated sheep.
    Brockman RP
    Can J Physiol Pharmacol; 1985 Apr; 63(4):346-9. PubMed ID: 3891048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of adrenergic drugs on glucose and plasma glucagon and insulin responses to xylazine in sheep.
    Muggaberg J; Brockman RP
    Res Vet Sci; 1982 Jul; 33(1):118-20. PubMed ID: 6753074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose uptake during centrally induced stress is insulin independent and enhanced by adrenergic blockade.
    Lekas MC; Fisher SJ; El-Bahrani B; van Delangeryt M; Vranic M; Shi ZQ
    J Appl Physiol (1985); 1999 Aug; 87(2):722-31. PubMed ID: 10444633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
    Banarer S; McGregor VP; Cryer PE
    Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in rat pancreatic B-cell function induced by prenatal exposure to cyproheptadine.
    Chow SA; Fischer LJ
    Diabetes; 1984 Jun; 33(6):572-5. PubMed ID: 6373461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
    Simonson DC; Koivisto V; Sherwin RS; Ferrannini E; Hendler R; Juhlin-Dannfelt A; DeFronzo RA
    J Clin Invest; 1984 Jun; 73(6):1648-58. PubMed ID: 6327767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute in-vivo effects of adrenocorticotrophin on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits: involvement of the alpha-adrenergic nervous system.
    Knudtzon J
    J Endocrinol; 1984 Mar; 100(3):345-52. PubMed ID: 6321628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of fetal rat endocrine pancreas to the diabetogenic action of cyproheptadine.
    Chow SA; Fischer LJ
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):264-77. PubMed ID: 3520954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenergic modulation of pancreatic glucagon secretion in man.
    Gerich JE; Langlois M; Noacco C; Schneider V; Forsham PH
    J Clin Invest; 1974 May; 53(5):1441-6. PubMed ID: 4825234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
    Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
    J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of the serotonin1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rats.
    Sugimoto Y; Yamada J; Kimura I; Watanabe Y; Horisaka K
    Jpn J Pharmacol; 1992 Oct; 60(2):145-8. PubMed ID: 1479742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon and insulin secretion and their biological activities in hypothermic rats.
    Helman A; Gilbert M; Pfister-Lemaire N; Réach G; Assan R
    Endocrinology; 1984 Nov; 115(5):1722-8. PubMed ID: 6436006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia.
    Baylor P; Shilo S; Zonszein J; Shamoon H
    Am J Physiol; 1986 Sep; 251(3 Pt 1):E322-7. PubMed ID: 3019152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.